Literature DB >> 17486666

Use of anxiolytic or hypnotic drugs and total mortality in a general middle-aged population.

Anne Margrethe Hausken1, Svetlana Skurtveit, Aage Tverdal.   

Abstract

PURPOSE: The aim of the study was to evaluate the effect of the consumption of anxiolytic or hypnotic drugs on total mortality in a general population.
METHODS: We followed a cohort of 7225 men and 7726 women aged 40-42 years who underwent health surveys in 1985-1989 in two Norwegian counties, with respect to deaths. Mean follow-up period was 18 years. The subjects were categorised according to frequency of anxiolytic or hypnotic drug use during the last month: daily, every week, less than every week and not used during the last month.
RESULTS: The proportion of anxiolytic or hypnotic drug users was 6.6% among men and 16.2% among women. Altogether 402 men and 290 women died. There was an increase in risk of death with an increase in frequency of use. Crude hazard ratios for men and women daily using anxiolytics or hypnotics were 3.1 (95%CI 2.0, 4.8) and 2.7 (1.9, 4.0), respectively, as compared with non-users last month. After adjusting painkiller use and smoking the hazard ratios were lowered, being 2.4 (1.5-4.0) (men) and 2.1 (1.4-3.2) (women). After additional adjustments for other possible confounders the hazard ratios were further attenuated to 1.5 (0.9-2.7) for men and 1.7 (1.1-2.6) for women.
CONCLUSIONS: Daily users of anxiolytic or hypnotic drugs in our study showed higher crude mortality than non-users. However, after adjusting lifestyle and socio-economic variables the difference was markedly reduced suggesting that the remaining excess mortality is due to residual confounding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17486666     DOI: 10.1002/pds.1417

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  21 in total

1.  Association between hypnotics use and increased mortality: causation or confounding?

Authors:  C Ineke Neutel; Helen L Johansen
Journal:  Eur J Clin Pharmacol       Date:  2015-04-07       Impact factor: 2.953

2.  Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data.

Authors:  Nicholas T Vozoris; Richard S Leung
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

3.  A nine-year follow-up study of sleep patterns and mortality in community-dwelling older adults in Taiwan.

Authors:  Hsi-Chung Chen; Tung-Ping Su; Pesus Chou
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

4.  Association of hypnotics with stroke risk: a population-based case-control study.

Authors:  Ching-Chih Lee; Kuan-Yi Tsai; Yeh-Ting Hung; Frank Huang-Chih Chou; Yung-Sung Huang
Journal:  Prim Care Companion CNS Disord       Date:  2014-03-27

Review 5.  Characterizing the Interrelationships of Prescription Opioid and Benzodiazepine Drugs With Worker Health and Workplace Hazards.

Authors:  Michele Kowalski-McGraw; Judith Green-McKenzie; Sudha P Pandalai; Paul A Schulte
Journal:  J Occup Environ Med       Date:  2017-11       Impact factor: 2.162

6.  Use of Sedative-Hypnotics and Mortality: A Population-Based Retrospective Cohort Study.

Authors:  Jae-Won Choi; Joonki Lee; Sun Jae Jung; Aesun Shin; Yu Jin Lee
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

Review 7.  Mortality Risk of Hypnotics: Strengths and Limits of Evidence.

Authors:  Daniel F Kripke
Journal:  Drug Saf       Date:  2016-02       Impact factor: 5.606

8.  Cohort study of the association of hypnotic use with mortality in postmenopausal women.

Authors:  Arthur Hartz; John Jacob Ross
Journal:  BMJ Open       Date:  2012-09-12       Impact factor: 2.692

9.  A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing.

Authors:  Ingunn Fride Tvete; Trine Bjørner; Ivar Andreas Aursnes; Tor Skomedal
Journal:  BMJ Open       Date:  2013-10-04       Impact factor: 2.692

Review 10.  Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.

Authors:  Lone Baandrup; Bjørn H Ebdrup; Jesper Ø Rasmussen; Jane Lindschou; Christian Gluud; Birte Y Glenthøj
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.